Extended Antibiotic Therapy in Postoperative of Laparoscopic Cholecystectomy in Acute Cholecystitis
Information source: Hospital Italiano de Buenos Aires
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Acute Cholecystitis
Intervention: Amoxicillin clavulanic (Drug); Placebo (Drug)
Phase: Phase 4
Status: Recruiting
Sponsored by: Hospital Italiano de Buenos Aires Official(s) and/or principal investigator(s): Martin de Santibañes, MD, Principal Investigator, Affiliation: Hospital Italiano de Buenos Aires Diego Giunta, MD, Study Director, Affiliation: Hospital Italiano de Buenos Aires
Overall contact: Pablo A. Pellegrini, MD, Phone: 0054-011 1559679722, Email: pablo.pellegrini@hospitalitaliano.org.ar
Summary
Acute cholecystitis (AC) is a very common complication of cholelithiasis, encountered in 20%
of symptomatic patients.
Nowadays laparoscopic cholecystectomy (LC) is the standard treatment in mild and moderates
forms of diseases and antibiotic therapy in the postoperatory of these patients remains
under discussion. However in the beginning, AC presents itself as an steril process, the
obstruction of the cystic duct initiates a cascade of inflammation, ischaemia and necrosis,
as well as bacterial proliferation within the gallbladder lumen. Bactibilia was a
significant factor associated with total, as well as infectious, operative complications.
Regarding this, for some authors, monotherapy with amoxicillin clavulanic (AMC) would be the
best treatment after LC in patients with mild and moderate cholecystitis without
intraoperative complications such as bile peritonitis, cholangitis, gallbladder perforation
or abscess. In the other hand, others do not prescribe antimicrobial treatment after surgery
in these selected patients.
There is controversy regarding the postoperative treatment with antibiotics in patients with
mild and moderate cholecystitis and all the evidence about this topic.
Therefore, investigators decided to conduct a prospective randomized study in patients
undergoing laparoscopic cholecystectomy for acute mild and moderate cholecystitis cancer.
The patients will be randomized to receive AMC or placebo after surgery. With this study
investigators intend to prove that are no clinical differences in postoperative outcomes
between patients treated with AMC and placebo.
The primary aim of the trial is to assess that there are no benefits in the use of
postoperative antibiotics in patients whit mild or moderate acute cholecystitis in whom a
laparoscopic cholecystectomy was performed.
Clinical Details
Official title: Extended Antibiotic Therapy in Postoperative of Laparoscopic Cholecystectomy Due to Acute Cholecystitis. Is it Necessary?
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Investigator), Primary Purpose: Treatment
Primary outcome: Incidence of infectious postoperative complications
Secondary outcome: Number of days of hospital stay or readmissions.Number of surgical reinterventions or reoperations.
Detailed description:
Double blind randomized clinical trial
Eligibility
Minimum age: 18 Years.
Maximum age: 85 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- 18 to 85 years old
- Patients with diagnose of mild or moderate acute cholecystitis.
- Underwent laparoscopic cholecystectomy on Italian Hospital of Buenos Aires
Exclusion Criteria:
- They refuse to participate from the trial or the process of informed consent.
- Have known allergies or hypersensitivity to Mosapride or lactose (used for placebo).
- Patients with severe cholecystitis
- Patients with moderate cholecystitis who presents liver abscess, gallbladder abscess,
cholangitis or bile peritonitis.
- Intraoperative findings like liver cancer, liver metastases, common bile duct stones
or gallbladder carcinoma.
- Patients with conversion to laparotomy
- Previous treatment with antibiotics for more than five days.
- Patients with active oncological diseases, AIDS, diabetes, transplanted.
Locations and Contacts
Pablo A. Pellegrini, MD, Phone: 0054-011 1559679722, Email: pablo.pellegrini@hospitalitaliano.org.ar
Hospital Italiano de Buenos Aires, Capital Federal, Buenos Aires 1199, Argentina; Recruiting Pablo A. Pellegrini, MD, Phone: 54 11 59679722, Email: pablo.pellegrini@hospitalitaliano.org.ar Pablo A. Pellegrini, MD, Principal Investigator Agustin DIetrich, MD, Sub-Investigator Oscar M. Mazza, MD, Sub-Investigator Laura Barcan, MD, Sub-Investigator
Additional Information
Related publications: Strasberg SM. Clinical practice. Acute calculous cholecystitis. N Engl J Med. 2008 Jun 26;358(26):2804-11. doi: 10.1056/NEJMcp0800929. Review. Erratum in: N Engl J Med. 2008 Jul 17;359(3):325. Yoshida M, Takada T, Kawarada Y, Tanaka A, Nimura Y, Gomi H, Hirota M, Miura F, Wada K, Mayumi T, Solomkin JS, Strasberg S, Pitt HA, Belghiti J, de Santibanes E, Fan ST, Chen MF, Belli G, Hilvano SC, Kim SW, Ker CG. Antimicrobial therapy for acute cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg. 2007;14(1):83-90. Epub 2007 Jan 30. Yildiz B, Abbasoglu O, Tirnaksiz B, Hamaloglu E, Ozdemir A, Sayek I. Determinants of postoperative infection after laparoscopic cholecystectomy. Hepatogastroenterology. 2009 May-Jun;56(91-92):589-92. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187-96. doi: 10.1097/SLA.0b013e3181b13ca2. Yokoe M, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Gomi H, Pitt HA, Gouma DJ, Garden OJ, Büchler MW, Kiriyama S, Kimura Y, Tsuyuguchi T, Itoi T, Yoshida M, Miura F, Yamashita Y, Okamoto K, Gabata T, Hata J, Higuchi R, Windsor JA, Bornman PC, Fan ST, Singh H, de Santibanes E, Kusachi S, Murata A, Chen XP, Jagannath P, Lee S, Padbury R, Chen MF; Tokyo Guidelines Revision Committee. New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo Guidelines. J Hepatobiliary Pancreat Sci. 2012 Sep;19(5):578-85. doi: 10.1007/s00534-012-0548-0. Kanafani ZA, Khalifé N, Kanj SS, Araj GF, Khalifeh M, Sharara AI. Antibiotic use in acute cholecystitis: practice patterns in the absence of evidence-based guidelines. J Infect. 2005 Aug;51(2):128-34. Epub 2005 Jan 20. Review. Grande M, Torquati A, Farinon AM. Wound infection after cholecystectomy. Correlation between bacteria in bile and wound infection after operation on the gallbladder for acute and chronic gallstone disease. Eur J Surg. 1992 Feb;158(2):109-12. Galili O, Eldar S Jr, Matter I, Madi H, Brodsky A, Galis I, Eldar S Sr. The effect of bactibilia on the course and outcome of laparoscopic cholecystectomy. Eur J Clin Microbiol Infect Dis. 2008 Sep;27(9):797-803. doi: 10.1007/s10096-008-0504-8. Epub 2008 Mar 28.
Starting date: February 2014
Last updated: March 19, 2015
|